Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Current Deferred Revenue (2020 - 2022)

Scienture Holdings (SCNX) has disclosed Current Deferred Revenue for 3 consecutive years, with $5127.0 as the latest value for Q4 2022.

  • Quarterly Current Deferred Revenue changed N/A to $5127.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $5127.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $5127.0 for FY2022, N/A changed from the prior year.
  • Current Deferred Revenue hit $5127.0 in Q4 2022 for Scienture Holdings, up from $996.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $305972.0 in Q1 2020 to a low of $996.0 in Q1 2022.
  • Historically, Current Deferred Revenue has averaged $55944.8 across 3 years, with a median of $7563.5 in 2020.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 96.73% in 2021 and later tumbled 90.04% in 2022.
  • Year by year, Current Deferred Revenue stood at $10000.0 in 2020, then changed by 0.0% to $10000.0 in 2021, then tumbled by 48.73% to $5127.0 in 2022.
  • Business Quant data shows Current Deferred Revenue for SCNX at $5127.0 in Q4 2022, $996.0 in Q1 2022, and $10000.0 in Q1 2021.